Stocks and Investing Stocks and Investing
Wed, October 2, 2019
Tue, October 1, 2019
Mon, September 30, 2019
Fri, September 27, 2019
Thu, September 26, 2019
Wed, September 25, 2019
Tue, September 24, 2019
Mon, September 23, 2019
Fri, September 20, 2019
Thu, September 19, 2019
Wed, September 18, 2019

Kyle Rose Upgraded (ZBH) to Strong Buy and Increased Target to $167 on, Sep 18th, 2019


Published on 2024-10-26 16:19:14 - WOPRAI, Kyle Rose
  Print publication without navigation


Kyle Rose of Canaccord Genuity, Upgraded "Zimmer Biomet Holdings, Inc." (ZBH) to Strong Buy and Increased Target from $137 to $167 on, Sep 18th, 2019.

Kyle has made no other calls on ZBH in the last 4 months.



There are 7 other peers that have a rating on ZBH. Out of the 7 peers that are also analyzing ZBH, 1 agrees with Kyle's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Travis Steed of "Barclays" Upgraded from Sell to Hold and Increased Target to $140 on, Tuesday, July 30th, 2019


These are the ratings of the 6 analyists that currently disagree with Kyle


  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $158 on, Monday, September 9th, 2019
  • David Toung of "Argus Research" Upgraded from Hold to Strong Buy on, Monday, August 12th, 2019
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $158 on, Friday, August 2nd, 2019
  • Lawrence Keusch of "Raymond James" Maintained at Buy with Increased Target to $150 on, Monday, July 29th, 2019
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $150 on, Monday, July 29th, 2019
  • Jeff Johnson of "Baird" Upgraded from Hold to Buy and Increased Target to $154 on, Monday, July 29th, 2019